A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

被引：0
作者：
Yeka Adoke
Rella Zoleko-Manego
Serge Ouoba
Alfred B. Tiono
Grace Kaguthi
Juvêncio Eduardo Bonzela
Tran Thanh Duong
Alain Nahum
Marielle Bouyou-Akotet
Bernhards Ogutu
Alphonse Ouedraogo
Fiona Macintyre
Andreas Jessel
Bart Laurijssens
Mohammed H. Cherkaoui-Rbati
Cathy Cantalloube
Anne Claire Marrast
Raphaël Bejuit
David White
Timothy N. C. Wells
Florian Wartha
Didier Leroy
Afizi Kibuuka
Ghyslain Mombo-Ngoma
Daouda Ouattara
Irène Mugenya
Bui Quang Phuc
Francis Bohissou
Denise P. Mawili-Mboumba
Fredrick Olewe
Issiaka Soulama
Halidou Tinto
机构：
[1] Infectious Diseases Research Collaboration (IDRC),Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Dep. of Medicine
[2] Centre de Recherches Médicales de Lambaréné (CERMEL),Unité de Recherche Clinique de Nanoro
[3] University Medical Centre Hamburg-Eppendorf,Unité de Recherche Clinique de Banfora, C/H Régional de Banfora
[4] Institut de Recherche en Sciences de La Santé,Département de Parasitologie
[5] Centre National de Recherche Et de Formation Sur Le Paludisme (CNRFP),Mycologie
[6] Kenya Medical Research Institute-Centre for Respiratory Diseases Research (KEMRI-CRDR),Médecine Tropicale, Faculté de Médecine Et Des Sciences de La Santé
[7] Chokwe Health Research and Training Centre,Unité de Recherche Clinique de Niangoloko, S/C Centre Medical de Niangoloko
[8] National Institute of Malariology,Institute for Tropical Medicine
[9] Parasitology and Entomology,undefined
[10] Centre de Recherche Entomologique de Cotonou (CREC) and Hôpital La Croix de Zinvié,undefined
[11] Université Des Sciences de La Santé,undefined
[12] Kenya Medical Research Institute,undefined
[13] Centre National de Recherche Et de Formation Sur Le Paludisme (CNRFP),undefined
[14] Medicines for Malaria Venture (MMV),undefined
[15] Sanofi Research and Development,undefined
[16] BEL Pharm Consulting,undefined
[17] Sanofi Research and Development,undefined
[18] IQVIA CEVA,undefined
[19] University of Tübingen,undefined
来源：
Malaria Journal | / 20卷
关键词：
Ferroquine; Combination treatment; Pharmacokinetics/pharmacodynamics; Exposure–response; C580Y; mutation; Resistance; Parasite clearance; Vomiting;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 199 条
[51]  
Fairhurst RM(undefined) malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study undefined undefined undefined-undefined
[52]  
Amaratunga C(undefined)A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early undefined undefined undefined-undefined
[53]  
Lim P(undefined) in an induced blood-stage malaria infection study undefined undefined undefined-undefined
[54]  
Suon S(undefined)Phase I randomized dose-ascending placebo-controlled trials of ferroquine–a candidate anti-malarial drug–in adults with asymptomatic Plasmodium falciparum infection undefined undefined undefined-undefined
[55]  
Blasco B(undefined)undefined undefined undefined undefined-undefined
[56]  
Leroy D(undefined)undefined undefined undefined undefined-undefined
[57]  
Fidock DA(undefined)undefined undefined undefined undefined-undefined
[58]  
Wells TN(undefined)undefined undefined undefined undefined-undefined
[59]  
van Huijsduijnen R(undefined)undefined undefined undefined undefined-undefined
[60]  
Van Voorhis WC(undefined)undefined undefined undefined undefined-undefined
12345678910